Phase II trial of VP16-213 in squamous cell carcinoma of the head and neck.

Subjects

Subjects :

Adult
Aged
Drug Evaluation
Etoposide adverse effects
Female
Humans
Male
Middle Aged
Carcinoma, Squamous Cell drug therapy
Etoposide therapeutic use
Head and Neck Neoplasms drug therapy

Details

Language :

English

ISSN :

0277-5379

Volume :

23

Issue :

5

Database :

MEDLINE

Journal :

European journal of cancer & clinical oncology

Publication Type :

Academic Journal

Accession number :

3653180

Full Text :

https://doi.org/10.1016/0277-5379(87)90323-3